{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:20:49Z","timestamp":1793503249193,"version":"4.5.0"},"reference-count":556,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1159596"],"award-info":[{"award-number":["APP1159596"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.redox.2021.101896","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T11:08:33Z","timestamp":1613473713000},"page":"101896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies"],"prefix":"10.1016","volume":"41","author":[{"given":"L.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gholam Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dharmasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Pountney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.F.","family":"Tonissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Mellick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Yanatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","article-title":"2010 Alzheimer's disease facts and figures","volume":"6","year":"2010","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"10159","key":"10.1016\/j.redox.2021.101896_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"9423","key":"10.1016\/j.redox.2021.101896_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2021.101896_bib5","first-page":"983245","article-title":"Chelators in the treatment of iron accumulation in Parkinson\u2019s disease","author":"Mounsey","year":"2012","journal-title":"Int. J. Cell Biol."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00702-019-02138-1","article-title":"Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis","volume":"127","author":"Devos","year":"2020","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002512-199914020-00004","article-title":"The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease","volume":"14","author":"Jellinger","year":"1999","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.redox.2021.101896_bib9","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1073\/pnas.0912925107","article-title":"Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol","volume":"107","author":"Richardson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00109-009-0565-x","article-title":"The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia","volume":"88","author":"Richardson","year":"2010","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood-2004-10-3856","article-title":"Iron trafficking in the mitochondrion: novel pathways revealed by disease","volume":"105","author":"Napier","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib12","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1038\/s41598-017-12862-x","article-title":"alpha-Synuclein impairs ferritinophagy in the retinal pigment epithelium: implications for retinal iron dyshomeostasis in Parkinson's disease","volume":"7","author":"Baksi","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"alpha-Synuclein and dopamine at the crossroads of Parkinson's disease","volume":"33","author":"Venda","year":"2010","journal-title":"Trends Neurosci."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fnmol.2017.00455","article-title":"New progress on the role of glia in iron metabolism and iron-induced degeneration of dopamine neurons in Parkinson's Disease","volume":"10","author":"Xu","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2021.101896_bib17","series-title":"Oxford Textbook of Medicine","first-page":"3998","author":"J","year":"1996"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92295","article-title":"alpha-Synuclein in gut endocrine cells and its implications for Parkinson's disease","volume":"2","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1172\/JCI78361","article-title":"Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells","volume":"125","author":"Bohorquez","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"Pt B","key":"10.1016\/j.redox.2021.101896_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","article-title":"Parkinson's disease from the gut","volume":"1693","author":"Liddle","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101896_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.redox.2021.101896_bib22","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1353-8020(09)70770-9","article-title":"Non-motor extranigral signs and symptoms in Parkinson's disease","volume":"15","author":"Wolters","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neulet.2005.02.030","article-title":"Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease","volume":"381","author":"Michell","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1212\/WNL.0b013e3181cff6d5","article-title":"alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure","volume":"74","author":"Shishido","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archneur.57.4.470","article-title":"Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study","volume":"57","author":"Rinne","year":"2000","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.redox.2021.101896_bib28","first-page":"908306","article-title":"Visual symptoms in Parkinson\u2019s disease","author":"Armstrong","year":"2011","journal-title":"Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181515","article-title":"Effectiveness of physical activity on patients with depression and Parkinson's disease: a systematic review","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7861\/clinmedicine.16-4-365","article-title":"New concepts in the pathogenesis and presentation of Parkinson's disease","volume":"16","author":"Sauerbier","year":"2016","journal-title":"Clin. Med."},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib32","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2174\/0929867325666171129124616","article-title":"Metals and Parkinson's disease: mechanisms and biochemical processes","volume":"25","author":"Bjorklund","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5321","key":"10.1016\/j.redox.2021.101896_bib34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.redox.2021.101896_bib35","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilarino-Guell","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.redox.2021.101896_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.12.001","article-title":"Role of the VPS35 D620N mutation in Parkinson's disease","volume":"36","author":"Mohan","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"6701","key":"10.1016\/j.redox.2021.101896_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jgg.2016.05.005","article-title":"Parkin somatic mutations link melanoma and Parkinson's Disease","volume":"43","author":"Levin","year":"2016","journal-title":"J. Genet. Genom."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","article-title":"DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism","volume":"24","author":"Bonifati","year":"2003","journal-title":"Neurol. Sci."},{"issue":"5674","key":"10.1016\/j.redox.2021.101896_bib41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"7113","key":"10.1016\/j.redox.2021.101896_bib42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"issue":"Pt 8","key":"10.1016\/j.redox.2021.101896_bib43","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease","volume":"131","author":"Pan","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000110175","article-title":"Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease","volume":"8","author":"Ngim","year":"1989","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib45","first-page":"856","article-title":"Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter","volume":"46","author":"Wang","year":"1989","journal-title":"Br. J. Ind. Med."},{"key":"10.1016\/j.redox.2021.101896_bib46","first-page":"865319","article-title":"Manganese-induced parkinsonism due to ephedrone abuse","author":"Sikk","year":"2011","journal-title":"Parkinsons Dis."},{"issue":"2\u20133","key":"10.1016\/j.redox.2021.101896_bib47","first-page":"239","article-title":"Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease","volume":"20","author":"Gorell","year":"1999","journal-title":"Neurotoxicology"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib48","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1212\/WNL.42.7.1328","article-title":"Parkinson's disease and exposure to agricultural work and pesticide chemicals","volume":"42","author":"Semchuk","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2021.101896_bib49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson's disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2021.101896_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2013.11.003","article-title":"Rotenone and paraquat perturb dopamine metabolism: a computational analysis of pesticide toxicity","volume":"315","author":"Qi","year":"2014","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib52","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s12035-015-9198-y","article-title":"Paraquat induces cell death through impairing mitochondrial membrane permeability","volume":"53","author":"Huang","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib53","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4656","key":"10.1016\/j.redox.2021.101896_bib55","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"issue":"5798","key":"10.1016\/j.redox.2021.101896_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/289537a0","article-title":"Dendritic release of dopamine in the substantia nigra","volume":"289","author":"Cheramy","year":"1981","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib57","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1471-4159.1989.tb01863.x","article-title":"Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum","volume":"52","author":"Nissbrandt","year":"1989","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib58","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993","article-title":"Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium","volume":"13","author":"Pifl","year":"1993","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1471-4159.1994.63020640.x","article-title":"Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion","volume":"63","author":"Bates","year":"1994","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib60","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1471-4159.1986.tb01768.x","article-title":"Studies on the neurotoxicity of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine: inhibition of NAD-Linked substrate oxidation by its metabolite, 1-Methyl-4-Phenylpyridinium","volume":"46","author":"Vyas","year":"1986","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib61","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1471-4159.1990.tb01962.x","article-title":"Effects of 1-Methyl-4-Phenyl- 1,2,3,6-Tetrahydropyridine and 1 -Methyl-4-Phenylpyridinium ion on ATP levels of mouse brain synaptosomes","volume":"54","author":"Scotcher","year":"1990","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib62","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/S0021-9258(17)41844-8","article-title":"Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations","volume":"269","author":"Gluck","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib63","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib64","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/jnc.13128","article-title":"The regulation of p53 up-regulated modulator of apoptosis by JNK\/c-Jun pathway in beta-amyloid-induced neuron death","volume":"134","author":"Akhter","year":"2015","journal-title":"J. Neurochem."},{"issue":"6735","key":"10.1016\/j.redox.2021.101896_bib65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/20959","article-title":"Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC","volume":"399","author":"Shimizu","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib66","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2021.101896_bib67","series-title":"Merritt's Neurology\/","first-page":"679","author":"Rowland","year":"2000"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib69","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","article-title":"Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled","volume":"26","author":"Keeney","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07469.x","article-title":"Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease","volume":"991","author":"Fiskum","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(93)90341-J","article-title":"Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease","volume":"627","author":"Hartley","year":"1993","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib72","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib73","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 3","key":"10.1016\/j.redox.2021.101896_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj20021302","article-title":"Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron","volume":"369","author":"Watts","year":"2003","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib75","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/10408398.2011.573885","article-title":"L-arginine and nitric oxide in CNS function and neurodegenerative diseases","volume":"53","author":"Virarkar","year":"2013","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib76","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood.V86.8.3211.3211","article-title":"The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells","volume":"86","author":"Richardson","year":"1995","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib77","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1074\/jbc.M006318200","article-title":"Nitrogen monoxide (no) and glucose: unexpected links between energy metabolism and no-mediated iron mobilization from cells","volume":"276","author":"Watts","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib78","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1046\/j.1432-1033.2002.02987.x","article-title":"The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells. NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner","volume":"269","author":"Watts","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib79","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1021\/bi991099t","article-title":"Nitrogen monoxide activates iron regulatory protein 1 RNA-binding activity by two possible Mechanisms: effect on the [4Fe-4S] cluster and iron mobilization from cells","volume":"39","author":"Wardrop","year":"2000","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0006-291X(91)91390-X","article-title":"Inactivation of ribonucleotide reductase by nitric oxide","volume":"179","author":"Lepoivre","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4787","key":"10.1016\/j.redox.2021.101896_bib81","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.2432665","article-title":"Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite","volume":"235","author":"Hibbs","year":"1987","journal-title":"Science"},{"issue":"5639","key":"10.1016\/j.redox.2021.101896_bib82","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/270735a0","article-title":"Depression of macrophages in mice drinking hyperchlorinated water","volume":"270","author":"Fidler","year":"1977","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib83","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1073\/pnas.87.3.1223","article-title":"EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages","volume":"87","author":"Lancaster","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-291X(90)91919-J","article-title":"IFN-\u03b3-activated macrophages: detection by electron paramagnetic resonance of complexes between L-Arginine-derived nitric oxide and non-heme iron proteins","volume":"166","author":"Pellat","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(91)80894-9","article-title":"Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands","volume":"289","author":"Vanin","year":"1991","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib86","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.freeradbiomed.2011.06.030","article-title":"Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: biological parameters of assembly and disappearance","volume":"51","author":"Hickok","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib87","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0006-291X(84)90288-2","article-title":"Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages","volume":"123","author":"Hibbs","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4300","key":"10.1016\/j.redox.2021.101896_bib88","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.327547","article-title":"Macrophage tumor killing: influence of the local environment","volume":"197","author":"Hibbs","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.redox.2021.101896_bib89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2014.07.002","article-title":"Glutathione S-transferase and MRP1 form an integrated system involved in the storage and transport of dinitrosyl-dithiolato iron complexes in cells","volume":"75","author":"Lok","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib93","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.redox.2021.101896_bib94","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","article-title":"Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity","volume":"9","author":"Tabrizi","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.redox.2021.101896_bib95","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","article-title":"The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity","volume":"20","author":"Ostrerova-Golts","year":"2000","journal-title":"J. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.redox.2021.101896_bib96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj20021525","article-title":"1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide","volume":"371","author":"Kalivendi","year":"2003","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1040-8428(01)00213-X","article-title":"The iron metabolism of neoplastic cells: alterations that facilitate proliferation?","volume":"42","author":"Kwok","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib98","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/157340708786305952","article-title":"Iron chelators as potential therapeutic agents for Parkinson's disease","volume":"4","author":"Perez","year":"2008","journal-title":"Curr. Bioact. Compd."},{"issue":"7954","key":"10.1016\/j.redox.2021.101896_bib99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","article-title":"On-off\" effects in patients with Parkinson's disease on chronic levodopa therapy","volume":"1","author":"Marsden","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030719","article-title":"Novel approaches for the treatment of alzheimer's and Parkinson's disease","volume":"20","author":"Van Bulck","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cells8020179","article-title":"Switching on endogenous metal binding proteins in Parkinson's Disease","volume":"8","author":"McLeary","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib102","first-page":"31","article-title":"The role of iron in cell cycle progression and the proliferation of neoplastic cells","volume":"1603","author":"Le","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib103","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/cas.14496","article-title":"Ferroptosis at the crossroads of infection, aging and cancer","volume":"111","author":"Toyokuni","year":"2020","journal-title":"Canc. Sci."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib104","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MCO.0b013e32831ba07c","article-title":"Role of iron in neurotoxicity: a cause for concern in the elderly?","volume":"12","author":"Stankiewicz","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"8569","key":"10.1016\/j.redox.2021.101896_bib105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J. Neural. Transm."},{"issue":"18","key":"10.1016\/j.redox.2021.101896_bib107","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib108","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib109","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"11\u201312","key":"10.1016\/j.redox.2021.101896_bib110","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib111","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imr.12533","article-title":"Ferroptosis: bug or feature?","volume":"277","author":"Dixon","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101896_bib112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib113","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","article-title":"NRF2 is a major target of ARF in p53-independent tumor suppression","volume":"68","author":"Chen","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2021.101896_bib115","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"7545","key":"10.1016\/j.redox.2021.101896_bib116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101896_bib117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.bi.48.070179.001025","article-title":"Reduction of ribonucleotides","volume":"48","author":"Thelander","year":"1979","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib118","first-page":"402","article-title":"Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311","volume":"9","author":"Chaston","year":"2003","journal-title":"Clin. Canc. Res."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib119","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.111.071324","article-title":"The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity","volume":"79","author":"Yu","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V64.3.748.748","article-title":"Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation","volume":"64","author":"Lederman","year":"1984","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib121","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V98.3.842","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression","volume":"98","author":"Gao","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib122","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/carcin\/bgg116","article-title":"The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1","volume":"24","author":"Liang","year":"2003","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib123","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/carcin\/bgg042","article-title":"Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1\/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation","volume":"24","author":"Le","year":"2003","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib124","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2007-03-076737","article-title":"Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1\/WAF1 by iron depletion","volume":"110","author":"Fu","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib125","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bbamcr.2016.09.011","article-title":"The anticancer agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), up-regulates the AMPK-dependent energy homeostasis pathway in cancer cells","volume":"1863","author":"Krishan","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib126","first-page":"165657","article-title":"Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells","author":"Krishan","year":"1866","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib127","first-page":"165970","article-title":"The anti-Tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-MTORC1 axis","author":"Krishan","year":"1866","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101896_bib128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcp.2016.04.001","article-title":"Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): activation of PERK\/eIF2alpha, IRE1alpha, ATF6 and calmodulin kinase","volume":"109","author":"Merlot","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"issue":"6641","key":"10.1016\/j.redox.2021.101896_bib130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian proton-coupled metal-ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng0897-383","article-title":"Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene","volume":"16","author":"Fleming","year":"1997","journal-title":"Nat. Genet."},{"issue":"6771","key":"10.1016\/j.redox.2021.101896_bib132","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/35001596","article-title":"Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter","volume":"403","author":"Donovan","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib133","doi-asserted-by":"crossref","first-page":"129685","DOI":"10.1016\/j.bbagen.2020.129685","article-title":"The new role of poly (rC)-binding proteins as iron transport chaperones: proteins that could couple with inter-organelle interactions to safely traffic iron","volume":"1864","author":"Yanatori","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib134","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0167-4889(92)90131-T","article-title":"A low-spin iron complex in human melanoma and rat hepatoma cells and a high-spin iron(II) complex in rat hepatoma cells","volume":"1135","author":"St Pierre","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib135","first-page":"35","article-title":"Function and regulation of transferrin and ferritin","volume":"35","author":"Ponka","year":"1998","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib136","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1432-1327.2000.01079.x","article-title":"The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell","volume":"267","author":"Richardson","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4157(96)00014-7","article-title":"The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells","volume":"1331","author":"Richardson","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0098-2997(81)90003-0","article-title":"Transferrin, biochemistry, physiology and clinical significance","volume":"4","author":"Morgan","year":"1981","journal-title":"Mol. Aspect. Med."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib139","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1073\/pnas.95.3.1148","article-title":"Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron\u2009transport","volume":"95","author":"Fleming","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1523-1755.2002.00405.x","article-title":"Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice","volume":"62","author":"Canonne-Hergaux","year":"2002","journal-title":"Kidney Int."},{"issue":"5509","key":"10.1016\/j.redox.2021.101896_bib141","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.1057206","article-title":"An iron-regulated ferric reductase associated with the absorption of dietary iron","volume":"291","author":"McKie","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib142","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/nu7042274","article-title":"Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation","volume":"7","author":"Lane","year":"2015","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.redox.2021.101896_bib143","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1016\/S0021-9258(17)44637-0","article-title":"The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes","volume":"258","author":"Iacopetta","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcp.1041610119","article-title":"Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake","volume":"161","author":"Richardson","year":"1994","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tcb.2006.12.003","article-title":"Iron uptake and metabolism in the new millennium","volume":"17","author":"Dunn","year":"2007","journal-title":"Trends Cell Biol."},{"issue":"20","key":"10.1016\/j.redox.2021.101896_bib146","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.79.20.6186","article-title":"Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment","volume":"79","author":"van Renswoude","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib147","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.80.8.2258","article-title":"pH and the recycling of transferrin during receptor-mediated endocytosis","volume":"80","author":"Dautry-Varsat","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib148","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng1658","article-title":"Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells","volume":"37","author":"Ohgami","year":"2005","journal-title":"Nat. Genet."},{"issue":"42","key":"10.1016\/j.redox.2021.101896_bib149","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1038\/sj.onc.1210442","article-title":"The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark \u2013 from iron metabolism to tumorigenesis","volume":"26","author":"Suryo Rahmanto","year":"2007","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib150","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib151","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1182\/blood.V89.7.2611","article-title":"Can ferritin provide iron for hemoglobin synthesis?","volume":"89","author":"Ponka","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib152","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-019-09098-w","article-title":"Cryo-EM structure of the human ferritin-transferrin receptor 1 complex","volume":"10","author":"Montemiglio","year":"2019","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.redox.2021.101896_bib153","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","article-title":"Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family","volume":"274","author":"Kawabata","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.redox.2021.101896_bib154","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1074\/jbc.M908846199","article-title":"Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo","volume":"275","author":"Kawabata","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101896_bib156","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.10.413","article-title":"Non-transferrin-bound iron transporters","volume":"133","author":"Knutson","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"5853","key":"10.1016\/j.redox.2021.101896_bib157","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/296171a0","article-title":"Human melanoma-associated antigen p97 is structurally and functionally related to transferrin","volume":"296","author":"Brown","year":"1982","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib158","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1083\/jcb.131.4.939","article-title":"A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells","volume":"131","author":"Danielsen","year":"1995","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib159","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1073\/pnas.77.4.2183","article-title":"Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms","volume":"77","author":"Woodbury","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"42","key":"10.1016\/j.redox.2021.101896_bib160","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1038\/sj.onc.1210442","article-title":"The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis","volume":"26","author":"Suryo Rahmanto","year":"2007","journal-title":"Oncogene"},{"issue":"2\u20133","key":"10.1016\/j.redox.2021.101896_bib161","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-5793(92)80060-T","article-title":"Human melanotransferrin (p97) has only one functional iron-binding site","volume":"298","author":"Baker","year":"1992","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib162","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2005-10-4174","article-title":"Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivo","volume":"107","author":"Sekyere","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib163","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.bbamcr.2009.02.003","article-title":"Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): No overt alteration in phenotype","volume":"1793","author":"Rahmanto","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib164","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0167-4889(91)90133-I","article-title":"The uptake of inorganic iron complexes by human melanoma cells","volume":"1093","author":"Richardson","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(90)90018-9","article-title":"The uptake of iron and transferrin by the human malignant melanoma cell","volume":"1053","author":"Richardson","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib166","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/carcin\/bgl045","article-title":"The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis","volume":"27","author":"Dunn","year":"2006","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib167","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/carcin\/bgm096","article-title":"Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo","volume":"28","author":"Suryo Rahmanto","year":"2007","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01767-9","article-title":"Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease","volume":"845","author":"Yamada","year":"1999","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib169","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/nm1196-1230","article-title":"Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease","volume":"2","author":"Kennard","year":"1996","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0893-133X(00)00230-X","article-title":"Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease","volume":"25","author":"Kim","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 2","key":"10.1016\/j.redox.2021.101896_bib171","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/bj20030240","article-title":"Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease","volume":"374","author":"Desrosiers","year":"2003","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib172","first-page":"457","article-title":"Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier","volume":"10","author":"Moroo","year":"2003","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib173","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbadis.2004.06.002","article-title":"The transferrin homologue, melanotransferrin (p97), is rapidly catabolized by the liver of the rat and does not effectively donate iron to the brain","volume":"1690","author":"Richardson","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib174","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1016\/S0021-9258(18)83758-9","article-title":"Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy","volume":"264","author":"Grootveld","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2005.06.025","article-title":"Identification of an intestinal heme transporter","volume":"122","author":"Shayeghi","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib176","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cmet.2006.12.004","article-title":"When is a heme transporter not a heme transporter? When it's a folate transporter","volume":"5","author":"Andrews","year":"2007","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib177","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib178","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"issue":"6817","key":"10.1016\/j.redox.2021.101896_bib179","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1189\/jlb.0706453","article-title":"CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system","volume":"82","author":"Schaer","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib181","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1182\/blood-2005-03-1014","article-title":"CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin","volume":"107","author":"Schaer","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib182","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.RES.0000247067.34173.1b","article-title":"Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin","volume":"99","author":"Schaer","year":"2006","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib183","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1097-2765(00)80425-6","article-title":"A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation","volume":"5","author":"McKie","year":"2000","journal-title":"Mol. Cell"},{"issue":"26","key":"10.1016\/j.redox.2021.101896_bib184","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.1074\/jbc.M000713200","article-title":"A novel mammalian iron-regulated protein involved in intracellular iron metabolism","volume":"275","author":"Abboud","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/90038","article-title":"A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis","volume":"28","author":"Njajou","year":"2001","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib186","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2003.12.008","article-title":"Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis","volume":"40","author":"Wallace","year":"2004","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2004.12.002","article-title":"Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features","volume":"34","author":"Sham","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib188","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/5979","article-title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse","volume":"21","author":"Vulpe","year":"1999","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib189","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/S0021-9258(18)96527-0","article-title":"The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum","volume":"241","author":"Osaki","year":"1966","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib190","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/S0021-9258(18)62284-7","article-title":"The mobilization of iron from the perfused mammalian liver by a serum copper enzyme","volume":"246","author":"Osaki","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib191","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI106460","article-title":"The role of ceruloplasmin in iron metabolism","volume":"49","author":"Roeser","year":"1970","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib192","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1152\/ajplegacy.1973.224.3.514","article-title":"Effects of iron on copper metabolism and copper on iron metabolism in rats","volume":"224","author":"Owen","year":"1973","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib193","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","article-title":"Aceruloplasminemia: molecular characterization of this disorder of iron metabolism","volume":"92","author":"Harris","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib194","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng0395-267","article-title":"A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans","volume":"9","author":"Yoshida","year":"1995","journal-title":"Nat. Genet."},{"issue":"5351","key":"10.1016\/j.redox.2021.101896_bib195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.279.5351.714","article-title":"Role of ceruloplasmin in cellular iron uptake","volume":"279","author":"Mukhopadhyay","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib196","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0022-2143(99)90166-X","article-title":"Role of ceruloplasmin and ascorbate in cellular iron release","volume":"134","author":"Richardson","year":"1999","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib197","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1020775101654","article-title":"Aceruloplasminemia, an inherited disorder of iron metabolism","volume":"16","author":"Miyajima","year":"2003","journal-title":"Biometals"},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib198","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/S0021-9258(19)44032-5","article-title":"The reaction of ferric salts with transferrin","volume":"248","author":"Bates","year":"1973","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib199","first-page":"782","article-title":"Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems","volume":"63","author":"Vanin","year":"1998","journal-title":"Biochemistry (Mosc.)"},{"issue":"20","key":"10.1016\/j.redox.2021.101896_bib200","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1073\/pnas.0602515103","article-title":"Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1","volume":"103","author":"Watts","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib201","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1074\/jbc.M111.310987","article-title":"Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes","volume":"287","author":"Lok","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"53","key":"10.1016\/j.redox.2021.101896_bib202","doi-asserted-by":"crossref","first-page":"27042","DOI":"10.1074\/jbc.M116.763714","article-title":"A nitric oxide storage and transport system that protects activated macrophages from endogenous nitric oxide cytotoxicity","volume":"291","author":"Lok","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5 Pt A","key":"10.1016\/j.redox.2021.101896_bib203","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbagen.2017.02.021","article-title":"Regulation and control of nitric oxide (NO) in macrophages: protecting the \"professional killer cell\" from its own cytotoxic arsenal via MRP1 and GSTP1","volume":"1861","author":"Kovacevic","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"7498","key":"10.1016\/j.redox.2021.101896_bib205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib206","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph11040114","article-title":"The role of NCOA4-mediated ferritinophagy in health and disease","volume":"11","author":"Santana-Codina","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib207","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00702-011-0588-7","article-title":"Ultrastructural aspects of iron storage, transport and metabolism","volume":"118","author":"Iancu","year":"2011","journal-title":"J. Neural. Transm."},{"issue":"27","key":"10.1016\/j.redox.2021.101896_bib208","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.1074\/jbc.C100141200","article-title":"A human mitochondrial ferritin encoded by an intronless gene","volume":"276","author":"Levi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib209","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1369\/jhc.7A7273.2007","article-title":"Mitochondrial ferritin expression in adult mouse tissues","volume":"55","author":"Santambrogio","year":"2007","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib210","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2002-07-2006","article-title":"Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia","volume":"101","author":"Cazzola","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib211","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bbamcr.2012.05.010","article-title":"Mammalian iron metabolism and its control by iron regulatory proteins","volume":"1823","author":"Anderson","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101896_bib212","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1073\/pnas.93.9.4345","article-title":"Differences in the RNA binding sites of iron regulatory proteins and potential target diversity","volume":"93","author":"Butt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2021.101896_bib213","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1074\/jbc.271.9.4900","article-title":"Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences (*)","volume":"271","author":"Henderson","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.redox.2021.101896_bib214","doi-asserted-by":"crossref","first-page":"17481","DOI":"10.1016\/S0021-9258(17)32466-3","article-title":"Optimal sequence and structure of iron-responsive elements. Selection of RNA stem-loops with high affinity for iron regulatory factor","volume":"269","author":"Henderson","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib215","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1074\/jbc.273.6.3740","article-title":"Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization","volume":"273","author":"Schalinske","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib216","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nsmb1222","article-title":"Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency","volume":"14","author":"Sanchez","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib217","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/j.1460-2075.1991.tb07715.x","article-title":"Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA","volume":"10","author":"Cox","year":"1991","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib218","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0092-8674(88)90098-0","article-title":"A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm","volume":"53","author":"Mullner","year":"1988","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib219","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1432-1327.1999.00447.x","article-title":"The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake","volume":"263","author":"Wardrop","year":"1999","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(01)03189-1","article-title":"Iron-dependent regulation of the divalent metal ion transporter","volume":"509","author":"Gunshin","year":"2001","journal-title":"FEBS Lett."},{"issue":"47","key":"10.1016\/j.redox.2021.101896_bib221","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.redox.2021.101896_bib222","doi-asserted-by":"crossref","first-page":"31217","DOI":"10.1074\/jbc.M110.149161","article-title":"Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1","volume":"285","author":"Cho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib223","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.gene.2019.06.012","article-title":"Relevance of the iron-responsive element (IRE) pseudotriloop structure for IRP1\/2 binding and validation of IRE-like structures using the yeast three-hybrid system","volume":"710","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.redox.2021.101896_bib224","first-page":"142372","article-title":"The anticholinesterase phenserine and its enantiomer posiphen as 5\u2019untranslated-region-directed translation blockers of the Parkinson\u2019s alpha synuclein expression","author":"Mikkilineni","year":"2012","journal-title":"Parkinsons Dis."},{"issue":"4854","key":"10.1016\/j.redox.2021.101896_bib225","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.2452485","article-title":"Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation","volume":"240","author":"Casey","year":"1988","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(93)90046-S","article-title":"Regulating the fate of mRNA: the control of cellular iron metabolism","volume":"72","author":"Klausner","year":"1993","journal-title":"Cell"},{"issue":"37","key":"10.1016\/j.redox.2021.101896_bib227","doi-asserted-by":"crossref","first-page":"21645","DOI":"10.1074\/jbc.270.37.21645","article-title":"Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome","volume":"270","author":"Guo","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5953","key":"10.1016\/j.redox.2021.101896_bib228","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.1176333","article-title":"Control of iron homeostasis by an iron-regulated ubiquitin ligase","volume":"326","author":"Vashisht","year":"2009","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib229","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1182\/blood-2008-04-150953","article-title":"Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2","volume":"112","author":"Foot","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib230","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1073\/pnas.192423399","article-title":"Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function","volume":"99","author":"Hubert","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5704","key":"10.1016\/j.redox.2021.101896_bib231","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib232","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.redox.2021.101896_bib233","doi-asserted-by":"crossref","first-page":"25450","DOI":"10.1074\/jbc.M113.471573","article-title":"Hepcidin bound to alpha2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels","volume":"288","author":"Huang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.redox.2021.101896_bib234","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1182\/blood-2009-01-201590","article-title":"Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood","volume":"113","author":"Peslova","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.V50.3.433.433","article-title":"Low molecular weight intracellular iron transport compounds","volume":"50","author":"Jacobs","year":"1977","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib236","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1182\/blood.V87.8.3477.bloodjournal8783477","article-title":"Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism","volume":"87","author":"Richardson","year":"1996","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.redox.2021.101896_bib237","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.M113.460253","article-title":"Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin","volume":"288","author":"Leidgens","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5880","key":"10.1016\/j.redox.2021.101896_bib238","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1126\/science.1157643","article-title":"A cytosolic iron chaperone that delivers iron to ferritin","volume":"320","author":"Shi","year":"2008","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib239","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41589-019-0330-6","article-title":"A PCBP1-BolA2 chaperone complex delivers iron for cytosolic [2Fe-2S] cluster assembly","volume":"15","author":"Patel","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib240","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI90519","article-title":"PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis","volume":"127","author":"Ryu","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib241","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20140225","article-title":"Chaperone protein involved in transmembrane transport of iron","volume":"462","author":"Yanatori","year":"2014","journal-title":"Biochem. J."},{"issue":"33","key":"10.1016\/j.redox.2021.101896_bib242","doi-asserted-by":"crossref","first-page":"17303","DOI":"10.1074\/jbc.M116.721936","article-title":"Iron export through the transporter ferroportin 1 is modulated by the iron chaperone PCBP2","volume":"291","author":"Yanatori","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib243","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","article-title":"DMT1 and iron transport","volume":"133","author":"Yanatori","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"32","key":"10.1016\/j.redox.2021.101896_bib244","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1074\/jbc.M117.776021","article-title":"The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1\/cytochrome P450 reductase complex for heme catabolism and iron transfer","volume":"292","author":"Yanatori","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib245","doi-asserted-by":"crossref","first-page":"108071","DOI":"10.1016\/j.abb.2019.108071","article-title":"How iron is handled in the course of heme catabolism: integration of heme oxygenase with intracellular iron transport mechanisms mediated by poly (rC)-binding protein-2","volume":"672","author":"Yanatori","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib246","first-page":"165844","article-title":"Acireductone dioxygenase 1 (ADI1) is regulated by cellular iron by a mechanism involving the iron chaperone, PCBP1, with PCBP2 acting as a potential co-chaperone","author":"Bae","year":"1866","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib247","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.bbamcr.2016.09.008","article-title":"Erythroid cell mitochondria receive endosomal iron by a \"kiss-and-run\" mechanism","volume":"1863","author":"Hamdi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib248","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood-2007-01-068148","article-title":"Direct interorganellar transfer of iron from endosome to mitochondrion","volume":"110","author":"Sheftel","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib249","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2004-06-2226","article-title":"Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib250","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.201602069","article-title":"Endosome-mitochondria interactions are modulated by iron release from transferrin","volume":"214","author":"Das","year":"2016","journal-title":"J. Cell Biol."},{"issue":"15","key":"10.1016\/j.redox.2021.101896_bib251","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/bloodadvances.2016003772","article-title":"A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2","volume":"1","author":"Khalil","year":"2017","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib252","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/7727","article-title":"Transferrin receptor is necessary for development of erythrocytes and the nervous system","volume":"21","author":"Levy","year":"1999","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib253","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"5990","key":"10.1016\/j.redox.2021.101896_bib254","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101896_bib255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(92)91652-U","article-title":"Iron and transferrin uptake by brain and cerebrospinal fluid in the rat","volume":"592","author":"Crowe","year":"1992","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib256","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.82.19.6706","article-title":"Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry","volume":"82","author":"Bloch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib257","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0361-9230(87)90122-5","article-title":"Transferrin gene expression in choroid plexus of the adult rat brain","volume":"18","author":"Bloch","year":"1987","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib258","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<486::AID-JNR6>3.0.CO;2-I","article-title":"Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid","volume":"54","author":"Moos","year":"1998","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib259","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.1991.tb06355.x","article-title":"Transferrin and iron uptake by the brain: effects of altered iron status","volume":"57","author":"Taylor","year":"1991","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib261","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00415-004-0445-9","article-title":"Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review","volume":"251","author":"Russo","year":"2004","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib262","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-510X(90)90183-N","article-title":"Transferrin receptors in rat central nervous system: an immunocytochemical study","volume":"98","author":"Giometto","year":"1990","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib263","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jnr.490230315","article-title":"Increase of transferrin receptors and iron uptake in regenerating motor neurons","volume":"23","author":"Graeber","year":"1989","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib264","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z","article-title":"Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system","volume":"375","author":"Moos","year":"1996","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.0178","article-title":"Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor","volume":"142","author":"Broadwell","year":"1996","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib266","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12640-010-9195-x","article-title":"Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia","volume":"19","author":"Bishop","year":"2011","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib267","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1997.69020443.x","article-title":"Transport of iron in the blood-brain-cerebrospinal fluid system","volume":"69","author":"Bradbury","year":"1997","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib268","doi-asserted-by":"crossref","first-page":"28194","DOI":"10.3390\/ijms161226095","article-title":"Old things new view: ascorbic acid protects the brain in neurodegenerative disorders","volume":"16","author":"Covarrubias-Pinto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib269","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.bbamcr.2013.02.010","article-title":"Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism","volume":"1833","author":"Lane","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2021.101896_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2014.07.007","article-title":"The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption!","volume":"75","author":"Lane","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib271","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00429-017-1383-5","article-title":"Human astrocytes: structure and functions in the healthy brain","volume":"222","author":"Vasile","year":"2017","journal-title":"Brain Struct. Funct."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib272","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1083\/jcb.40.3.648","article-title":"Junctions between intimately apposed cell membranes in the vertebrate brain","volume":"40","author":"Brightman","year":"1969","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib273","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1136(199805)23:1<1::AID-GLIA1>3.0.CO;2-B","article-title":"Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: a confocal microscopy study","volume":"23","author":"Kacem","year":"1998","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib274","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib275","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s11064-007-9375-0","article-title":"The pivotal role of astrocytes in the metabolism of iron in the brain","volume":"32","author":"Dringen","year":"2007","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib276","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1471-4159.2003.02142.x","article-title":"The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain","volume":"88","author":"Moos","year":"2004","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib277","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1014464514793","article-title":"A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus","volume":"30","author":"Wang","year":"2001","journal-title":"J. Neurocytol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib278","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1471-4159.2007.04976.x","article-title":"Iron trafficking inside the brain","volume":"103","author":"Moos","year":"2007","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib279","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbadis.2013.04.007","article-title":"Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden","volume":"1832","author":"Pelizzoni","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib280","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00702-010-0420-9","article-title":"Synergistic accumulation of iron and zinc by cultured astrocytes","volume":"117","author":"Bishop","year":"2010","journal-title":"J. Neural. Transm."},{"issue":"32","key":"10.1016\/j.redox.2021.101896_bib281","doi-asserted-by":"crossref","first-page":"20185","DOI":"10.1074\/jbc.272.32.20185","article-title":"A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes","volume":"272","author":"Patel","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib282","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1074\/jbc.275.6.4305","article-title":"Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain","volume":"275","author":"Patel","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.redox.2021.101896_bib283","doi-asserted-by":"crossref","first-page":"27144","DOI":"10.1074\/jbc.M301988200","article-title":"Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system","volume":"278","author":"Jeong","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib284","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1523\/JNEUROSCI.5328-11.2012","article-title":"Iron efflux from astrocytes plays a role in remyelination","volume":"32","author":"Schulz","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2015.02.015","article-title":"The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to \u03b1-synuclein inclusions","volume":"65","author":"Radford","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib286","article-title":"Extracellular alpha-synuclein promotes a neuroinhibitory secretory phenotype in astrocytes","volume":"10","author":"Vieira","year":"2020","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib287","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib288","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s12035-013-8586-4","article-title":"Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration","volume":"49","author":"Zhang","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib289","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410260115","article-title":"Do oligodendrocytes mediate iron regulation in the human brain?","volume":"26","author":"Gerber","year":"1989","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/glia.20784","article-title":"Oligodendrocytes and myelination: the role of iron","volume":"57","author":"Todorich","year":"2009","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib291","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.2008.05678.x","article-title":"Tim-2 is the receptor for H-ferritin on oligodendrocytes","volume":"107","author":"Todorich","year":"2008","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.redox.2021.101896_bib292","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.82.13.4553","article-title":"Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution","volume":"82","author":"Hill","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib293","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-3806(86)90111-2","article-title":"Immunocytochemical distribution of transferrin and its receptor in the developing chicken nervous system","volume":"30","author":"Oh","year":"1986","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib294","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3940(87)90557-X","article-title":"Cellular distribution of transferrin immunoreactivity in the developing rat brain","volume":"78","author":"M\u2205llg\u00e5rd","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(86)90576-7","article-title":"The distribution of transferrin immunoreactivity in the rat central nervous system","volume":"368","author":"Connor","year":"1986","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib296","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jnr.490170108","article-title":"Development of transferrin-positive oligodendrocytes in the rat central nervous system","volume":"17","author":"Connor","year":"1987","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib297","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbagen.2011.10.016","article-title":"Functional roles of transferrin in the brain","volume":"1820","author":"Leitner","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib298","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jnr.10619","article-title":"Myelination and motor coordination are increased in transferrin transgenic mice","volume":"72","author":"Saleh","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib299","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jnutbio.2014.07.003","article-title":"Iron and mechanisms of emotional behavior","volume":"25","author":"Kim","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib300","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1096-9861(19980831)398:3<420::AID-CNE8>3.0.CO;2-1","article-title":"Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency","volume":"398","author":"Moos","year":"1998","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib301","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870130205","article-title":"Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease","volume":"13","author":"Banati","year":"1998","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib302","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib303","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1096\/fj.12-222257","article-title":"Secreted protein lipocalin-2 promotes microglial M1 polarization","volume":"27","author":"Jang","year":"2013","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib304","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","article-title":"Heterogeneity of microglial activation in the innate immune response in the brain","volume":"4","author":"Colton","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.redox.2021.101896_bib305","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib306","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/jcp.22640","article-title":"Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia","volume":"226","author":"Yuan","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib308","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1471-4159.1988.tb13250.x","article-title":"Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents","volume":"50","author":"Rausch","year":"1988","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib309","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib310","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","article-title":"Selective increase of iron in substantia nigra zona compacta of parkinsonian brains","volume":"56","author":"Sofic","year":"1991","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib311","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057904","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up","volume":"8","author":"Ulla","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib312","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jmri.21563","article-title":"MRI assessment of basal ganglia iron deposition in Parkinson's disease","volume":"28","author":"Wallis","year":"2008","journal-title":"J. Magn. Reson. Imag."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib313","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162460","article-title":"Quantitative susceptibility mapping in Parkinson's Disease","volume":"11","author":"Langkammer","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib314","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.mri.2013.04.015","article-title":"Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients","volume":"31","author":"Wang","year":"2013","journal-title":"Magn. Reson. Imag."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib315","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.20550","article-title":"In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage","volume":"20","author":"Zecca","year":"2005","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib316","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","article-title":"Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib317","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/cr.2010.20","article-title":"Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent","volume":"20","author":"Jiang","year":"2010","journal-title":"Cell Res."},{"issue":"47","key":"10.1016\/j.redox.2021.101896_bib318","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib319","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2009.11.004","article-title":"Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease","volume":"48","author":"Song","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib320","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1073\/pnas.94.10.4890","article-title":"A new link between monoamine oxidase and mitochondrial electron flow","volume":"94","author":"Cohen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib321","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib322","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2021.101896_bib323","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0002-9440(10)64249-6","article-title":"Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies","volume":"161","author":"Power","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib324","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.58.6.956","article-title":"Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam","volume":"58","author":"Cox","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2021.101896_bib325","doi-asserted-by":"crossref","first-page":"110717","DOI":"10.1016\/j.jinorgbio.2019.110717","article-title":"Iron and other metals in the pathogenesis of Parkinson's disease: toxic effects and possible detoxification","volume":"199","author":"Bjorklund","year":"2019","journal-title":"J. Inorg. Biochem."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib326","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00702-017-1695-x","article-title":"Alpha-synuclein and iron: two keys unlocking Parkinson's disease","volume":"124","author":"Lingor","year":"2017","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib327","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"issue":"5646","key":"10.1016\/j.redox.2021.101896_bib328","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib329","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib330","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib331","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1326-4-9","article-title":"\u03b1-Synuclein and neuronal cell death","volume":"4","author":"Cookson","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2021.101896_bib332","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib333","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1039\/C4MT00339J","article-title":"Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease","volume":"7","author":"Carboni","year":"2015","journal-title":"Metallomics"},{"issue":"6645","key":"10.1016\/j.redox.2021.101896_bib334","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib335","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib336","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101896_bib337","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib338","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.redox.2021.101896_bib339","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1385\/MN:31:1-3:273","article-title":"Environmental toxins and alpha-synuclein in Parkinson's disease","volume":"31","author":"Liu","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2021.101896_bib340","doi-asserted-by":"crossref","first-page":"16293","DOI":"10.1038\/s41598-020-73207-9","article-title":"Metal ions shape \u03b1-synuclein","volume":"10","author":"Moons","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib341","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib342","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib343","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/acschemneuro.9b00092","article-title":"Identification of a new \u03b1-Synuclein aggregation inhibitor via mass spectrometry based screening","volume":"10","author":"Xu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib344","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies","volume":"157","author":"Duda","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"5493","key":"10.1016\/j.redox.2021.101896_bib345","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib346","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1039\/C3SC53461H","article-title":"An iron\u2013dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta","volume":"5","author":"Hare","year":"2014","journal-title":"Chem. Sci."},{"issue":"15","key":"10.1016\/j.redox.2021.101896_bib347","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/ja5131726","article-title":"Elucidating the role of site-specific nitration of alpha-synuclein in the pathogenesis of Parkinson's disease via protein semisynthesis and mutagenesis","volume":"137","author":"Burai","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"20","key":"10.1016\/j.redox.2021.101896_bib348","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib349","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"issue":"6109","key":"10.1016\/j.redox.2021.101896_bib350","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.redox.2021.101896_bib351","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 3","key":"10.1016\/j.redox.2021.101896_bib352","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S1353-8020(09)70802-8","article-title":"Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease","volume":"15","author":"Angot","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"31","key":"10.1016\/j.redox.2021.101896_bib353","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0906759106","article-title":"Is Parkinson's disease a prion disorder?","volume":"106","author":"Olanow","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib354","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib355","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/WCO.0000000000000215","article-title":"alpha-Synuclein and Lewy pathology in Parkinson's disease","volume":"28","author":"Kalia","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"23","key":"10.1016\/j.redox.2021.101896_bib356","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"Prusiner","year":"1998","journal-title":"Prions, Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib357","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/ars.2014.5874","article-title":"Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease","volume":"21","author":"Singh","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib358","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006115","article-title":"Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport","volume":"4","author":"Singh","year":"2009","journal-title":"PLoS One"},{"issue":"Suppl","key":"10.1016\/j.redox.2021.101896_bib359","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10","author":"Bossy-Wetzel","year":"2004","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib360","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/156720508786898523","article-title":"Metal catalyzed oxidation of alpha-synuclein--a role for oligomerization in pathology?","volume":"5","author":"Cole","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib361","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12013-007-0014-9","article-title":"Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane","volume":"47","author":"Beyer","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.redox.2021.101896_bib362","first-page":"108029","article-title":"Mitochondrial dysfunction and alpha-synuclein synaptic pathology in Parkinson's disease: who's on first?","author":"Zaltieri","year":"2015","journal-title":"Parkinsons Dis."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib363","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib364","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1110\/ps.9.12.2489","article-title":"Structural changes in alpha-synuclein affect its chaperone-like activity in vitro","volume":"9","author":"Kim","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.redox.2021.101896_bib365","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1074\/jbc.272.21.13717","article-title":"Raf-1 kinase and exoenzyme S interact with 14-3-6\u00b6 through a common site involving lysine 49*","volume":"272","author":"Zhang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib366","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1074\/jbc.272.21.13717","article-title":"Raf-1 kinase and exoenzyme S interact with 14-3-6\u00b6 through a common site involving lysine 49*","volume":"272","author":"Zhang","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib367","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib368","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11064-008-9599-7","article-title":"Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells","volume":"33","author":"Liu","year":"2008","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib369","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12264-007-0008-z","article-title":"Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene","volume":"23","author":"Gao","year":"2007","journal-title":"Neurosci. Bull."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib370","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2003.01742.x","article-title":"Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines","volume":"85","author":"Baptista","year":"2003","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib371","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2004.05.118","article-title":"Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells","volume":"367","author":"Yu","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"Pt 15","key":"10.1016\/j.redox.2021.101896_bib372","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib373","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3945\/jn.108.095224","article-title":"Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue","volume":"138","author":"Unger","year":"2008","journal-title":"J. Nutr."},{"issue":"3\u20134","key":"10.1016\/j.redox.2021.101896_bib374","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0091-3057(01)00563-9","article-title":"Iron deficiency decreases dopamine D1 and D2 receptors in rat brain","volume":"69","author":"Erikson","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib375","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/jn\/130.11.2831","article-title":"Iron deficiency alters dopamine transporter functioning in rat striatum","volume":"130","author":"Erikson","year":"2000","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib376","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jn\/133.4.1174","article-title":"Neonatal iron deficiency results in irreversible changes in dopamine function in rats","volume":"133","author":"Beard","year":"2003","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib377","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s12035-015-9146-x","article-title":"Alpha-synuclein over-expression induces increased iron accumulation and redistribution in iron-exposed neurons","volume":"53","author":"Ortega","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib378","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/900a5247-7d03-4686-a544-5f7f64c0aac5","article-title":"Alpha-synuclein is a cellular ferrireductase","volume":"6","author":"Davies","year":"2011","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.redox.2021.101896_bib379","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/acs.biochem.7b00257","article-title":"Steady-state kinetics of alpha-synuclein ferrireductase activity identifies the catalytically competent species","volume":"56","author":"McDowall","year":"2017","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbrc.2007.05.060","article-title":"Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease","volume":"359","author":"Bharathi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 3","key":"10.1016\/j.redox.2021.101896_bib381","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/bj3400821","article-title":"Copper(II)-induced self-oligomerization of alpha-synuclein","volume":"340","author":"Paik","year":"1999","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib382","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1471-4159.2003.01612.x","article-title":"Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2","volume":"84","author":"Lee","year":"2003","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib383","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101896_bib384","first-page":"129","article-title":"Tyrosine hydroxylase regulation in the central nervous system","volume":"53\u201354","author":"Masserano","year":"1983","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib386","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2008.02.014","article-title":"Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice","volume":"435","author":"Alerte","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib387","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib388","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0854.2008.00853.x","article-title":"Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling","volume":"10","author":"Ben Gedalya","year":"2009","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib389","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(84)90006-0","article-title":"Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes","volume":"39","author":"Hanover","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.redox.2021.101896_bib390","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2016.06.025","article-title":"Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: implications for visual manifestations of Parkinson's disease","volume":"97","author":"Baksi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib391","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2021.101896_bib392","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2017.02.001","article-title":"Mitochondrial ferritin protects SH-SY5Y cells against H2O2-induced oxidative stress and modulates \u03b1-synuclein expression","volume":"291","author":"Guan","year":"2017","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.redox.2021.101896_bib393","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib394","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.mp.4001937","article-title":"The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element","volume":"12","author":"Friedlich","year":"2007","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib395","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/WNR.0b013e328354a1f0","article-title":"alpha-Synuclein expression is modulated at the translational level by iron","volume":"23","author":"Febbraro","year":"2012","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib396","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2004-07-2722","article-title":"Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis","volume":"105","author":"Nie","year":"2005","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.redox.2021.101896_bib397","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3230539","article-title":"Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein\/NAC precursor that bind Abeta and NAC","volume":"323","author":"Jensen","year":"1997","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib398","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","article-title":"The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?","volume":"2","author":"Han","year":"1995","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib399","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00702-010-0513-5","article-title":"The alpha-synuclein 5\u2032untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen","volume":"118","author":"Rogers","year":"2011","journal-title":"J. Neural. Transm."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib400","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/ijms10031226","article-title":"Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element","volume":"10","author":"Olivares","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib401","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1101\/lm.052282.120","article-title":"Iron-responsive-like elements and neurodegenerative ferroptosis","volume":"27","author":"Rogers","year":"2020","journal-title":"Learn. Mem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib402","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1353-8020(00)00065-1","article-title":"Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain","volume":"7","author":"Trojanowski","year":"2001","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib403","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib404","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00702-010-0453-0","article-title":"Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells","volume":"118","author":"He","year":"2011","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2009.11.080","article-title":"Converse modulation of toxic alpha-synuclein oligomers in living cells by N'-benzylidene-benzohydrazide derivates and ferric iron","volume":"391","author":"Hillmer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib406","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"issue":"Suppl 6","key":"10.1016\/j.redox.2021.101896_bib407","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib408","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","article-title":"Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine","volume":"320","author":"Junn","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib409","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Epidemiology of Parkinson's Disease, Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib410","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"Faseb. J."},{"issue":"7601","key":"10.1016\/j.redox.2021.101896_bib411","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature17939","article-title":"Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression","volume":"533","author":"Soldner","year":"2016","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.redox.2021.101896_bib412","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib413","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.11001","article-title":"Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease","volume":"4","author":"Maraganore","year":"2011","journal-title":"J. Mov. Disord."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib414","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1073\/pnas.1905057117","article-title":"Translation of the intrinsically disordered protein alpha-synuclein is inhibited by a small molecule targeting its structured mRNA","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib415","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib416","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib417","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/cells7100154","article-title":"The interplay among PINK1\/PARKIN\/Dj-1 network during mitochondrial quality control in cancer biology: protein interaction analysis","volume":"7","author":"Salazar","year":"2018","journal-title":"Cells"},{"issue":"5604","key":"10.1016\/j.redox.2021.101896_bib418","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib419","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molbrainres.2004.09.004","article-title":"Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization","volume":"134","author":"Blackinton","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"16","key":"10.1016\/j.redox.2021.101896_bib421","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1073\/pnas.1133288100","article-title":"The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib422","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/ddi211","article-title":"Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis","volume":"14","author":"Zhang","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib423","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2021.101896_bib424","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gene.2005.06.040","article-title":"Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction","volume":"361","author":"Park","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.redox.2021.101896_bib425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-10-6583-5_8","article-title":"Regulation of signal transduction by DJ-1","volume":"1037","author":"Oh","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.redox.2021.101896_bib426","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1038\/ncomms7609","article-title":"The Parkinson's-associated protein DJ-1 regulates the 20S proteasome","volume":"6","author":"Moscovitz","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib427","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/ars.2010.3481","article-title":"The role of cysteine oxidation in DJ-1 function and dysfunction","volume":"15","author":"Wilson","year":"2011","journal-title":"Antioxidants Redox Signal."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib428","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1248\/bpb.25.853","article-title":"DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice","volume":"25","author":"Okada","year":"2002","journal-title":"Biol. Pharm. Bull."},{"issue":"29","key":"10.1016\/j.redox.2021.101896_bib429","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1073\/pnas.0708518105","article-title":"RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways","volume":"105","author":"van der Brug","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.redox.2021.101896_bib430","doi-asserted-by":"crossref","first-page":"37556","DOI":"10.1074\/jbc.M101730200","article-title":"DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor","volume":"276","author":"Takahashi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib431","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1158\/0008-5472.CAN-06-4556","article-title":"DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells","volume":"67","author":"Tillman","year":"2007","journal-title":"Canc. Res."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib432","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1074\/jbc.M311017200","article-title":"Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function","volume":"279","author":"Olzmann","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.redox.2021.101896_bib433","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/ddq113","article-title":"Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage","volume":"19","author":"Chen","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2021.101896_bib434","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00216","article-title":"Redox aspects of chaperones in cardiac function","volume":"9","author":"Penna","year":"2018","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib435","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/hmg\/ddl104","article-title":"Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease","volume":"15","author":"Tang","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib436","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddi007","article-title":"Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress","volume":"14","author":"Moore","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"31","key":"10.1016\/j.redox.2021.101896_bib437","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M113.482091","article-title":"Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity","volume":"288","author":"Bjorkblom","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.redox.2021.101896_bib438","doi-asserted-by":"crossref","first-page":"15123","DOI":"10.1523\/JNEUROSCI.4751-13.2014","article-title":"Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in Parkinson's disease models","volume":"34","author":"Choi","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib439","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12031-012-9904-4","article-title":"DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress","volume":"49","author":"Mullett","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.07.009","article-title":"SG2NA recruits DJ-1 and Akt into the mitochondria and membrane to protect cells from oxidative damage","volume":"75","author":"Tanti","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101896_bib441","doi-asserted-by":"crossref","first-page":"146641","DOI":"10.1016\/j.brainres.2019.146641","article-title":"DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN","volume":"1729","author":"Niki","year":"2020","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib442","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/onc.2011.268","article-title":"Consequences of DJ-1 upregulation following p53 loss and cell transformation","volume":"31","author":"Vasseur","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib443","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/10715760100301381","article-title":"DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin","volume":"35","author":"Mitsumoto","year":"2001","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2021.101896_bib444","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-10-6583-5_6","article-title":"The multifaceted roles of DJ-1 as an antioxidant","volume":"1037","author":"Raninga","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.redox.2021.101896_bib445","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib446","doi-asserted-by":"crossref","first-page":"12056","DOI":"10.1038\/s41598-018-30561-z","article-title":"Distribution of oxidized DJ-1 in Parkinson's disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin","volume":"8","author":"Mita","year":"2018","journal-title":"Sci. Rep."},{"issue":"7324","key":"10.1016\/j.redox.2021.101896_bib447","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101896_bib448","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0079-6123(10)83004-3","article-title":"What causes the death of dopaminergic neurons in Parkinson's disease?","volume":"183","author":"Surmeier","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib449","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1083\/jcb.200608073","article-title":"Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels","volume":"175","author":"Szabadkai","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.redox.2021.101896_bib450","first-page":"1","author":"Nicholls","year":"2002","journal-title":"Bioenergetics"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib451","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib452","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tins.2006.12.003","article-title":"Space, time and dopamine","volume":"30","author":"Arbuthnott","year":"2007","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib453","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s11064-007-9313-1","article-title":"Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures","volume":"32","author":"Gaasch","year":"2007","journal-title":"Neurochem. Res."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib454","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/ddi211","article-title":"Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis","volume":"14","author":"Zhang","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib455","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1074\/jbc.M111.299198","article-title":"YajL, prokaryotic homolog of parkinsonism-associated protein DJ-1, functions as a covalent chaperone for thiol proteome","volume":"287","author":"Le","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib456","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","article-title":"Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease","volume":"51","author":"Dolgacheva","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib457","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1254\/jphs.11151FP","article-title":"Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7","volume":"117","author":"Inden","year":"2011","journal-title":"J. Pharmacol. Sci."},{"issue":"37","key":"10.1016\/j.redox.2021.101896_bib458","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0703219104","article-title":"DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase","volume":"104","author":"Andres-Mateos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib459","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2004.03.110","article-title":"Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells","volume":"317","author":"Kinumi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.redox.2021.101896_bib460","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1073\/pnas.0402959101","article-title":"The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization","volume":"101","author":"Canet-Aviles","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib461","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1074\/jbc.M806599200","article-title":"Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1","volume":"284","author":"Blackinton","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101896_bib462","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.535112","article-title":"DJ-1 Is a copper chaperone acting on SOD1 activation","volume":"289","author":"Girotto","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib463","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/bi500294h","article-title":"Thermodynamic and structural characterization of the specific binding of Zn(II) to human protein DJ-1","volume":"53","author":"Tashiro","year":"2014","journal-title":"Biochem"},{"key":"10.1016\/j.redox.2021.101896_bib464","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00775-017-1509-5","article-title":"Intracellular metal binding and redox behavior of human DJ-1","volume":"23","author":"Barbieri","year":"2018","journal-title":"J. Biol. Inorg. Chem."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib465","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1600-0749.2004.00201.x","article-title":"The neuromelanin of human substantia nigra: physiological and pathogenic aspects","volume":"17","author":"Zucca","year":"2004","journal-title":"Pigm. Cell Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib466","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","article-title":"Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease","volume":"75","author":"Fedorow","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib467","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-4159.2008.05385.x","article-title":"Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease","volume":"106","author":"Sulzer","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2021.101896_bib468","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"45","key":"10.1016\/j.redox.2021.101896_bib469","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.0808768105","article-title":"New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals","volume":"105","author":"Zecca","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib470","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00702-006-0453-2","article-title":"Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability","volume":"113","author":"Zucca","year":"2006","journal-title":"J. Neural. Transm."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib471","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","article-title":"The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease","volume":"510","author":"Zecca","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2021.101896_bib472","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/brain\/123.12.2423","article-title":"Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence","volume":"123 Pt 12","author":"Graham","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib473","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0168-583X(99)00390-0","article-title":"Iron and cell death in Parkinson's disease: a nuclear microscopic study into iron-rich granules in the parkinsonian substantia nigra of primate models","volume":"158","author":"Thong","year":"1999","journal-title":"Nucl. Instrum. Methods Phys. Res. B"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib474","first-page":"277","article-title":"Iron histochemistry of the substantia nigra in Parkinson's disease","volume":"3","author":"Morris","year":"1994","journal-title":"Neurodegeneration"},{"issue":"6180","key":"10.1016\/j.redox.2021.101896_bib475","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib476","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1021\/ic060014r","article-title":"Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid","volume":"45","author":"Charkoudian","year":"2006","journal-title":"Inorg. Chem."},{"issue":"22","key":"10.1016\/j.redox.2021.101896_bib477","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib478","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/1673-5374.202928","article-title":"One of the most overlooked molecules in modern medicine, is not a spectator","volume":"12","author":"Haining","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib479","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0197-0186(02)00161-4","article-title":"Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein","volume":"42","author":"Fasano","year":"2003","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib480","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib481","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1471-4159.1995.65020923.x","article-title":"Mossbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra","volume":"65","author":"Gerlach","year":"1995","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib482","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbadis.2003.11.005","article-title":"M\u00f6ssbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra","volume":"1688","author":"Galazka-Friedman","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib483","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0925-4439(97)00014-8","article-title":"EPR investigations of the iron domain in neuromelanin","volume":"1361","author":"Aime","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib484","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10010006","article-title":"Cellular and molecular aspects of the beta-N-Methylamino-l-alanine (BMAA) mode of action within the neurodegenerative pathway: facts and controversy","volume":"10","author":"Delcourt","year":"2017","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib485","first-page":"414","article-title":"Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour","volume":"54","author":"Zecca","year":"2001","journal-title":"Mol. Pathol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib486","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1046\/j.1471-4159.1994.62052030.x","article-title":"Neuromelanin of the human substantia nigra: a mixed-type melanin","volume":"62","author":"Odh","year":"1994","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib487","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1046\/j.1471-4159.2000.0752583.x","article-title":"Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins","volume":"75","author":"Double","year":"2000","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib488","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0891-5849(96)00623-5","article-title":"Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study","volume":"23","author":"Shima","year":"1997","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib489","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0925-4439(96)00020-8","article-title":"Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease","volume":"1316","author":"Linert","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"44","key":"10.1016\/j.redox.2021.101896_bib490","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/onc.2016.81","article-title":"Rab1 in cell signaling, cancer and other diseases","volume":"35","author":"Yang","year":"2016","journal-title":"Oncogene"},{"issue":"7113","key":"10.1016\/j.redox.2021.101896_bib491","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.101896_bib492","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1196\/annals.1306.015","article-title":"Oxidative stress and redox-active iron in Alzheimer's disease","volume":"1012","author":"Honda","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.redox.2021.101896_bib493","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1306.026","article-title":"Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions","volume":"1012","author":"Richardson","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib494","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11011-012-9290-1","article-title":"The conundrum of iron in multiple sclerosis--time for an individualised approach","volume":"27","author":"van Rensburg","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib495","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","article-title":"Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review","volume":"9","author":"Sheykhansari","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib496","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/ars.2017.7493","article-title":"Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis?","volume":"29","author":"Moreau","year":"2018","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib497","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0887-8994(01)00303-4","article-title":"Iron and iron management proteins in neurobiology","volume":"25","author":"Connor","year":"2001","journal-title":"Pediatr. Neurol."},{"issue":"38","key":"10.1016\/j.redox.2021.101896_bib498","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.0906784106","article-title":"Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.redox.2021.101896_bib499","doi-asserted-by":"crossref","first-page":"20590","DOI":"10.1073\/pnas.1215349109","article-title":"Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia","volume":"109","author":"Whitnall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib500","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.parkreldis.2012.06.021","volume":"18","author":"Lehn","year":"2012","journal-title":"Neuroferritinopathy, Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib501","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.redox.2021.101896_bib502","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajh.25103","article-title":"The effect of iron chelation therapy on overall survival in sickle cell disease and beta-thalassemia: a systematic review","volume":"93","author":"Ballas","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib503","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.hoc.2018.04.005","article-title":"Critical issues in diamond-blackfan anemia and prospects for novel treatment","volume":"32","author":"Li","year":"2018","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.blre.2018.03.002","article-title":"To chelate or not to chelate in MDS: that is the question!","volume":"32","author":"Zeidan","year":"2018","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib505","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib506","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<299::AID-AJH9>3.0.CO;2-L","article-title":"Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism","volume":"58","author":"Richardson","year":"1998","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.redox.2021.101896_bib507","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V89.8.3025","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone","volume":"89","author":"Richardson","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib508","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2174\/0929867324666170920155439","article-title":"Cardioprotective potential of iron chelators and prochelators","volume":"26","author":"Jansova","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib509","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.hoc.2014.04.004","article-title":"Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease","volume":"28","author":"Marsella","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5662\/wjm.v6.i1.1","article-title":"New developments and controversies in iron metabolism and iron chelation therapy","volume":"6","author":"Kontoghiorghe","year":"2016","journal-title":"World J. Methodol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib511","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mlc.2001.114105","article-title":"The controversial role of deferiprone in the treatment of thalassemia","volume":"137","author":"Richardson","year":"2001","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib512","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211942","article-title":"Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox","volume":"14","author":"Olivieri","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib513","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-5793(79)80111-8","article-title":"Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent","volume":"97","author":"Ponka","year":"1979","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib514","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0304-4165(88)90197-3","article-title":"Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes","volume":"967","author":"Ponka","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib515","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840150323","article-title":"Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture","volume":"15","author":"Baker","year":"1992","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.redox.2021.101896_bib516","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1039\/b704102k","article-title":"Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity","author":"Bernhardt","year":"2007","journal-title":"Dalton Trans."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib517","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1980.tb07147.x","article-title":"Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone","volume":"45","author":"Cikrt","year":"1980","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib518","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1182\/blood-2002-08-2382","article-title":"Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells","volume":"101","author":"Link","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib519","first-page":"112","article-title":"Pyridoxal isonicotinoyl hydrazone: an effective iron-chelator after oral administration","volume":"27","author":"Brittenham","year":"1990","journal-title":"Semin. Hematol."},{"issue":"2\u20133","key":"10.1016\/j.redox.2021.101896_bib520","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0925-4439(01)00041-2","article-title":"Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron","volume":"1536","author":"Richardson","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"28","key":"10.1016\/j.redox.2021.101896_bib521","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1073\/pnas.0804261105","article-title":"The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation","volume":"105","author":"Whitnall","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib522","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","article-title":"Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats","volume":"46","author":"Shachar","year":"2004","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.redox.2021.101896_bib523","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib524","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2015.06.014","article-title":"The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death","volume":"463","author":"Mena","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.redox.2021.101896_bib525","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2021.101896_bib526","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nbd.2015.03.015","article-title":"Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse","volume":"81","author":"Lei","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"20 Suppl","key":"10.1016\/j.redox.2021.101896_bib527","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1046\/j.1440-1789.2000.00296.x","article-title":"Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals","author":"Tateishi","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.redox.2021.101896_bib528","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinorgbio.2017.03.003","article-title":"New tris(dopamine) derivative as an iron chelator. Synthesis, solution thermodynamic stability, and antioxidant research","volume":"171","author":"Zhang","year":"2017","journal-title":"J. Inorg. Biochem."},{"issue":"21","key":"10.1016\/j.redox.2021.101896_bib529","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1039\/C8DT01099D","article-title":"Novel chelators based on adamantane-derived semicarbazones and hydrazones that target multiple hallmarks of Alzheimer's disease","volume":"47","author":"Palanimuthu","year":"2018","journal-title":"Dalton Trans."},{"issue":"9","key":"10.1016\/j.redox.2021.101896_bib530","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/bph.14963","article-title":"Novel multifunctional iron chelators of the aroyl nicotinoyl hydrazone class that markedly enhance cellular NAD(+)\/NADH ratios","volume":"177","author":"Wu","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.redox.2021.101896_bib531","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00702-018-1942-9","article-title":"Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases","volume":"125","author":"Youdim","year":"2018","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.redox.2021.101896_bib532","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuropharm.2017.05.019","article-title":"A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses alpha-syn- and MPTP-induced toxicities in vivo","volume":"123","author":"Das","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.redox.2021.101896_bib533","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/acschemneuro.6b00356","article-title":"A novel iron(II) preferring dopamine agonist chelator as potential symptomatic and neuroprotective therapeutic agent for Parkinson\u2019s Disease","volume":"8","author":"Das","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2021.101896_bib534","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101896_bib535","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/156720508786898523","article-title":"Metal catalyzed oxidation of alpha-synuclein \u2013 a role for oligomerization in pathology?","volume":"5","author":"Cole","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.redox.2021.101896_bib536","doi-asserted-by":"crossref","first-page":"29065","DOI":"10.1074\/jbc.M109.000638","article-title":"Inhibition of prolyl hydroxylase protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib537","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","article-title":"Selective iron chelation in Friedreich ataxia: biologic and clinical implications","volume":"110","author":"Boddaert","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib538","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl\u2013derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.redox.2021.101896_bib539","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2021.101896_bib540","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1519473113","article-title":"Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice","volume":"113","author":"Matak","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.redox.2021.101896_bib541","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","article-title":"The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons","volume":"56","author":"Ben-Shachar","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2021.101896_bib542","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00167","article-title":"Regional siderosis: a new challenge for iron chelation therapy","volume":"4","author":"Cabantchik","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib543","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","article-title":"Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration","volume":"118","author":"Dexter","year":"2011","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib544","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib545","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2021.101896_bib546","series-title":"Oxidative Stress and Neuroprotection","first-page":"205","article-title":"Iron dyshomeostasis in Parkinson's disease","author":"Salazar","year":"2006"},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib547","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","article-title":"Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients","volume":"67","author":"Perry","year":"1986","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib548","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib549","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.redox.2021.101896_bib550","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410360306","article-title":"Glutathione-related enzymes in brain in Parkinson's disease","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.redox.2021.101896_bib551","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1471-4159.2004.02929.x","article-title":"Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease","volume":"92","author":"Hsu","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.redox.2021.101896_bib552","first-page":"RA17","article-title":"Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease","volume":"11","author":"Watanabe","year":"2005","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101896_bib553","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-977X(03)00065-8","article-title":"Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study","volume":"14","author":"Watanabe","year":"2004","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.redox.2021.101896_bib554","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1073\/pnas.86.10.3639","article-title":"Structure of activated aconitase: formation of the [4Fe-4S] cluster in the crystal","volume":"86","author":"Robbins","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.redox.2021.101896_bib555","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0403495101","article-title":"The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging","volume":"101","author":"Zecca","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2021.101896_bib556","series-title":"The Role of Iron in Neurodegeneration","first-page":"174","article-title":"Neurodegeneration : metallostasis and proteostasis","author":"Zucca","year":"2011"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:43:02Z","timestamp":1715038982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":556,"alternative-id":["S2213231721000446"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.101896","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.101896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101896"}}